Gu Jun-Xu, Huang Juan, Wang Kun, Yin Yue, Fang Jun-Ling, Zhang Ai-Min, Li Shan-Shan, Yao Xiao-Qin, Yang Ming, Zhang Na, Jia Mei, Su Ming
Department of Clinical Laboratory, Peking University People's Hospital, Beijing, PR China.
Department of Traditional Chinese Medicine, Peking University International Hospital, Beijing, PR China.
Heliyon. 2024 Sep 4;10(17):e37415. doi: 10.1016/j.heliyon.2024.e37415. eCollection 2024 Sep 15.
High circulatory lipoprotein(a) [Lp(a)] concentration promotes atherosclerosis; however, its efficacy in predicting the extent of atherosclerotic coronary heart disease (CHD) with coronary artery obstruction and major adverse cardiovascular events (MACEs) in diabetic patients remains questionable. This study aimed to examine whether elevated circulating Lp(a) levels exacerbate CHD and to assess their utility in predicting MACEs in individuals diagnosed with type 2 diabetes mellitus (T2DM).
In total, 4332 patients diagnosed with T2DM who underwent coronary angiography (CAG) were included and categorized into two groups (CHD and non-CHD) based on the CAG results. We used a correlation analysis to explore the potential links between the levels of circulating Lp(a) and CHD severity. Cox regression analysis was performed to evaluate MACEs.
The concentrations of circulating Lp(a) were markedly elevated in the CHD group and positively correlated with disease severity. Our results indicate that elevated circulating Lp(a) is a crucial risk factor that significantly contributes to both the progression and severity of CHD. The differences between the two groups are evident in the risk of CHD occurrence [odds ratio (OR) = 1.597, 95 % confidence interval (CI): 1.354-1.893, < 0.001], the different levels of vessel involvement (OR = 1.908 for triple-vessel . single-vessel disease, 95 % CI: 1.401-2.711, < 0.001), and their relation to the Gensini Score (OR = 2.002 for high . low GS, 95 % CI: 1.514-2.881, < 0.001). Over the course of the 7-year follow-up period, the multivariate Cox regression analysis indicated that increased levels Lp(a) levels are independently associated with the occurrence of MACEs [hazard ratio (HR) = 1.915, 95 % CI: 1.571-2.493, < 0.001].
We confirmed a positive correlation among circulating Lp(a) levels, CHD lesions count, and Gensini scores. Moreover, Lp(a) levels have predictive significance for the occurrence of MACEs in T2DM patients.
循环脂蛋白(a) [Lp(a)] 浓度升高会促进动脉粥样硬化;然而,其在预测糖尿病患者冠状动脉阻塞性动脉粥样硬化性冠心病(CHD)的严重程度和主要不良心血管事件(MACE)方面的有效性仍存在疑问。本研究旨在探讨循环Lp(a)水平升高是否会加重冠心病,并评估其在预测2型糖尿病(T2DM)患者MACE中的作用。
总共纳入了4332例接受冠状动脉造影(CAG)的T2DM患者,并根据CAG结果分为两组(冠心病组和非冠心病组)。我们采用相关性分析来探讨循环Lp(a)水平与冠心病严重程度之间的潜在联系。进行Cox回归分析以评估MACE。
冠心病组循环Lp(a)浓度显著升高,且与疾病严重程度呈正相关。我们的结果表明,循环Lp(a)水平升高是一个关键的危险因素,对冠心病的进展和严重程度均有显著影响。两组在冠心病发生风险[比值比(OR)=1.597,95%置信区间(CI):1.354 - 1.893,P<0.001]、不同血管受累程度(三支血管病变与单支血管病变相比,OR = 1.908,95%CI:1.401 - 2.711,P<0.001)以及与Gensini评分的关系(高Gensini评分与低Gensini评分相比,OR = 2.002,95%CI:1.514 - 2.881,P<0.001)方面存在明显差异。在7年的随访期间,多因素Cox回归分析表明,Lp(a)水平升高与MACE的发生独立相关[风险比(HR)=1.915,95%CI:1.571 - 2.493,P<0.001]。
我们证实了循环Lp(a)水平、冠心病病变数量和Gensini评分之间存在正相关。此外,Lp(a)水平对T2DM患者MACE的发生具有预测意义。